Publication:
Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.

Placeholder

Organizational Units

Program

Authors

Kilic, AYSU
Ustunova, SAVAŞ
Usta, C
Meral, İSMAİL
Demirci, Tansel
Gurel, Gurevin

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Source:

Keywords:

Keywords

Citation

Kilic A., Ustunova S., Usta C., Bulut H., Meral İ., Demirci T., Gurel G., -Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia/reperfusion injury and oxidative damage in isolated rat heart.-, Canadian journal of physiology and pharmacology, 2019

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals